Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05880849
PHASE1

Choline Effects - Pre-symptomatic AD

Sponsor: Paul E Schulz

View on ClinicalTrials.gov

Summary

The purpose of this study is to test the safety, tolerability, and effects of choline in people with increased risk of Alzheimer's Disease (AD), also known as pre-symptomatic AD. Choline is a dietary supplement, but is being investigated to see if it has any effects on the progression to AD.

Official title: Testing Whether Choline Normalizes Lipid Metabolism in APOE4 Carriers

Key Details

Gender

All

Age Range

55 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

15

Start Date

2023-06-26

Completion Date

2025-10-10

Last Updated

2026-04-22

Healthy Volunteers

No

Interventions

DRUG

Choline

Eight 275mg capsules taken orally twice daily (4 capsules with breakfast \& 4 capsules with dinner) x 180 days

Locations (1)

The University of Texas Health Science Center at Houston (UTHealth)

Houston, Texas, United States